REACH Interview Series: Tal Ben-Shahar

Tal Ben-Shahar is an American and Israeli teacher and writer in the areas of positive psychology and leadership. As a lecturer at Harvard University, Tal created two of the most popular courses in Harvard’s history. He has subsequently written several best-selling books and in 2011 co-founded Potentialife with Angus Ridgway, a company that provides leadership programs based on the science of behavioral change to organizations, schools and sports organizations globally. What you might not know about Tal is that he was a nationally ranked and championship squash player at Harvard as an undergraduate and that he and I were colleagues in the same Ph.D. program at Harvard, in Organizational Behavior and Psychology.

The Reach Interview Series is an informal dialogue between Andy Molinsky and respected thought leaders about the challenges of stepping outside your comfort zone, especially in the process of developing yourself as a leader.

 

Related Posts

When Crossing Cultures Use Global Dexterity

When Crossing Cultures Use Global Dexterity

Picture the following: Greg O’Leary, a 32-year-old mid-level manager, is in Shanghai for the first time to negotiate a critical deal with a distributor.

Read More

What Marissa Mayer (and Science) Says Are the Keys to Breaking Outside Your Comfort Zone

What Marissa Mayer (and Science) Says Are the Keys to Breaking Outside Your Comfort Zone

  You’d like to contribute to discussions at your company, but can never get a word in edgewise.

Read More

REACH Interview Series: Kathleen Kelly Janus

REACH Interview Series: Kathleen Kelly Janus

Kathleen Kelly Janus is a social entrepreneur, author and lecturer at Stanford University’s Program on Social Entrepreneurship.

Read More

In a New Culture Wait to Cut to the Chase

In a New Culture Wait to Cut to the Chase

Xavier Frei wanted to get down to business. A Zurich-born manager with 10 years’ experience working in Germany and Switzerland, Xavier had just landed a few days ago in Monterrey, Mexico, at a small pharmaceutical company that was recently purchased by Xavier’s company, a major European pharmaceutical firm.

Read More